Literature DB >> 8911314

Pulmonary artery growth after bidirectional cavopulmonary shunt: is there a cause for concern?

V M Reddy1, D B McElhinney, P Moore, E Petrossian, F L Hanley.   

Abstract

OBJECTIVE: Our objective was to analyze changes in pulmonary artery size after bidirectional cavopulmonary shunt.
METHODS: All 47 patients who underwent bidirectional cavopulmonary shunt between March 1990 and May 1995 who had preoperative and postoperative angiograms available for review were selected for study. This included 24 patients who had also undergone a modified Fontan operation. Clinical records were reviewed retrospectively and cross-sectional follow-up was obtained by direct physician contact. Angiograms were reveiwed, and the right and left pulmonary artery diameters were each measured at two locations: immediately distal to their origin and at the narrowest point. In addition, the lower lobe pulmonary artery branch was measured just distal to its origin. Cross-sectional areas (left, right, and total) at each point of measurement were indexed to body surface area. Angiographic and hemodynamic data were analyzed.
RESULTS: Changes in the various measures of pulmonary artery size after bidirectional cavopulmonary shunt varied considerably. On average the absolute diameters increased for all measures, but the increase in diameter was significant only for the lower lobe arteries. All pulmonary artery indices decreased on average, but these changes did not approach significance. Patients who underwent pulmonary artery augmentation at the time of bidirectional cavopulmonary shunt had significantly smaller pulmonary artery indices before pulmonary artery augmentation, relative to those who did not undergo pulmonary artery repair, and significantly greater changes (possibly to a large extent owing to pulmonary artery repair) in the right and left pulmonary artery index after bidirectional cavopulmonary shunt. Lower lobe indices did not differ preoperatively or exhibit different degrees of change in size between patients who did and did not undergo pulmonary artery repair. One patient died after Fontan completion (pulmonary artery index: 305 mm2/m2), and none of the factors analyzed correlated with Fontan outcomes.
CONCLUSIONS: A more appropriate measure of pulmonary artery growth is the indexed cross-sectional area of the lower lobe branch of the right and left pulmonary arteries, which is less likely to be altered surgically with systemic-pulmonary shunts, pulmonary artery repair, and the bidirectional cavopulmonary anastomosis itself. Pulmonary artery indices, including the lower lobe index, do not change significantly after bidirectional cavopulmonary shunt during medium-term follow-up and do not influence the Fontan outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8911314     DOI: 10.1016/S0022-5223(96)70131-9

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

1.  Pulmonary artery growth fails to match the increase in body surface area after the Fontan operation.

Authors:  G H Tatum; G Sigfússon; J A Ettedgui; J L Myers; S E Cyran; H S Weber; S A Webber
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

2.  Is morbidity influenced by staging in the fontan palliation? A single center review.

Authors:  K Francois; M Tamim; T Bove; K De Groote; D De Wolf; D Matthys; B Suys; H Verhaaren; G Van Nooten
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  Risk Factors for an Elevated Ventricular End-Diastolic Pressure Prior to the Fontan Operation.

Authors:  Matthew C Schwartz; Michael A Brock; David Nykanen; William DeCampli
Journal:  Pediatr Cardiol       Date:  2017-11-27       Impact factor: 1.655

4.  Intact right ventricle-pulmonary artery shunt after stage 2 palliation in hypoplastic left heart syndrome improves pulmonary artery growth.

Authors:  Mariel E Turner; Marc E Richmond; Jan M Quaegebeur; Amee Shah; Jonathan M Chen; Emile A Bacha; Julie A Vincent
Journal:  Pediatr Cardiol       Date:  2012-11-15       Impact factor: 1.655

5.  Fontan pathway growth: a quantitative evaluation of lateral tunnel and extracardiac cavopulmonary connections using serial cardiac magnetic resonance.

Authors:  Maria Restrepo; Lucia Mirabella; Elaine Tang; Christopher M Haggerty; Reza H Khiabani; Francis Fynn-Thompson; Anne Marie Valente; Doff B McElhinney; Mark A Fogel; Ajit P Yoganathan
Journal:  Ann Thorac Surg       Date:  2014-01-18       Impact factor: 4.330

Review 6.  Early determinants of pulmonary vascular remodeling in animal models of complex congenital heart disease.

Authors:  Sohrab Fratz; Jeffrey R Fineman; Agnes Görlach; Shruti Sharma; Peter Oishi; Christian Schreiber; Thomas Kietzmann; Ian Adatia; John Hess; Stephen M Black
Journal:  Circulation       Date:  2011-03-01       Impact factor: 29.690

7.  Risk factors for prolonged length of stay after the stage 2 procedure in the single-ventricle reconstruction trial.

Authors:  Steven M Schwartz; Minmin Lu; Richard G Ohye; Kevin D Hill; Andrew M Atz; Maryam Y Naim; Ismee A Williams; Caren S Goldberg; Alan Lewis; Frank Pigula; Peter Manning; Christian Pizarro; Paul Chai; Rachel McCandless; Carolyn Dunbar-Masterson; Jonathan R Kaltman; Kirk Kanter; Lynn A Sleeper; Julie V Schonbeck; Nancy Ghanayem
Journal:  J Thorac Cardiovasc Surg       Date:  2013-09-24       Impact factor: 5.209

8.  Stent implantation and balloon angioplasty for treatment of branch pulmonary artery stenosis in children.

Authors:  Lorenz Baerlocher; Oliver Kretschmar; Paul Harpes; Urs Arbenz; Felix Berger; Walter Knirsch
Journal:  Clin Res Cardiol       Date:  2007-12-28       Impact factor: 5.460

Review 9.  Late Fontan Circulatory Failure. What Drives Systemic Venous Congestion and Low Cardiac Output in Adult Fontan Patients?

Authors:  Alexander Van De Bruaene; Guido Claessen; Thomas Salaets; Marc Gewillig
Journal:  Front Cardiovasc Med       Date:  2022-03-14

Review 10.  Predictive Models for Pulmonary Artery Size in Fontan Patients.

Authors:  Akash Gupta; Chris Gillett; Patrick Gerard; Michael M H Cheung; Jonathan P Mynard; Ethan Kung
Journal:  J Cardiovasc Transl Res       Date:  2020-04-04       Impact factor: 4.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.